Cargando…

Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidence

AIMS: To describe the real‐world prevalence and consequences of hypertriglyceridaemia. MATERIALS AND METHODS: We searched two large patient databases, the National Health and Nutrition Examination Survey (NHANES) database (2007–2014) and the Optum Research Database, as well as electronic medical rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toth, Peter P., Fazio, Sergio, Wong, Nathan D., Hull, Michael, Nichols, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065050/ https://www.ncbi.nlm.nih.gov/pubmed/31742844 http://dx.doi.org/10.1111/dom.13921

Ejemplares similares

Hypertriglyceridaemia: contemporary management of a neglected cardiovascular risk factor
por: Khan, Tina Z., et al.
Publicado: (2021)

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

An unusual case of (pseudo)hypertriglyceridaemia
por: Speeckaert, Marijn M., et al.
Publicado: (2010)

Propofol: Hypertriglyceridaemia: case report
Publicado: (2022)

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
por: Toth, Peter P., et al.
Publicado: (2018)

Severe hypertriglyceridaemia during treatment with capecitabine
por: Javot, L, et al.
Publicado: (2011)

Acute Pancreatitis Secondary to Gestational Hypertriglyceridaemia
por: Cahalane, Alexis M., et al.
Publicado: (2012)

Role of the Enterocyte in Fructose-Induced Hypertriglyceridaemia
por: Steenson, Simon, et al.
Publicado: (2017)

Severe Hypertriglyceridaemia Leading to Factitious Hypobicarbonataemia
por: Roy, Sasmit, et al.
Publicado: (2021)

Comprehensive review on the pathogenesis of hypertriglyceridaemia-associated acute pancreatitis
por: Qiu, Minhao, et al.
Publicado: (2023)

Catecholamines/propofol/vasopressin: Hypertriglyceridaemia: case report
Publicado: (2020)

Hypertriglyceridaemia in pregnancy: an unexpected diagnosis and its management
por: Barclay, Kathryn, et al.
Publicado: (2022)

Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation
por: Greffrath, Wilhelm P., et al.
Publicado: (2018)

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
por: Parhofer, Klaus G, et al.
Publicado: (2020)

Hypertriglyceridaemia associated with propofol sedation in critically ill patients
por: Mateu, J., et al.
Publicado: (1996)

Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions
por: Sinclair, Ruth, et al.
Publicado: (2018)

Propofol: Hypertriglyceridaemia secondary to propofol infusion syndrome: case report.
Publicado: (2021)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Hypertriglyceridaemia-Induced Acute Pancreatitis: A Different Disease Phenotype
por: Dancu, Greta, et al.
Publicado: (2022)

Covid-19-vaccine-pfizer-biontech: Hypertriglyceridaemia: case report
Publicado: (2022)

Efficacy of insulin in treating severe hypertriglyceridaemia in the third trimester of pregnancy
por: Zhou, Dong, et al.
Publicado: (2022)

Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practice
por: Warden, Bruce A., et al.
Publicado: (2021)

Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options
por: Bashir, Bilal, et al.
Publicado: (2023)

Unmasking of severe hypertriglyceridaemia associated with antipsychotic therapy by atypical eruptive xanthomas
por: Kiedrowicz, Magdalena, et al.
Publicado: (2017)

Hypertriglyceridaemia delays pancreatic regeneration after acute pancreatitis in mice and patients
por: Yang, Na, et al.
Publicado: (2019)

Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19
por: Nakamura, Hideta, et al.
Publicado: (2020)

A Tale of Two New Targets for Hypertriglyceridaemia: Which Choice of Therapy?
por: Ward, Natalie C., et al.
Publicado: (2022)

Hypertriglyceridaemia as a risk factor for critical care admission in acute pancreatitis: A prospective study
por: Adiamah, Alfred, et al.
Publicado: (2020)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
por: Toth, Peter P., et al.
Publicado: (2019)

Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
por: Esan, Oluwayemisi, et al.
Publicado: (2020)

Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials
por: Calcaterra, Ilenia, et al.
Publicado: (2022)

Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice
por: Świątkiewicz, Iwona, et al.
Publicado: (2021)

Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
por: Chen, Guanmin, et al.
Publicado: (2021)

Atypical presentation of a middle age male with severe hypertriglyceridaemia: a case report
por: Albahrani, Ali I, et al.
Publicado: (2007)

The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study
por: Michie, C O, et al.
Publicado: (2010)

Lopinavir/ritonavir/tocilizumab: Hypertriglyceridaemia following off-label use: 2 case reports
Publicado: (2020)

Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis
por: Han, Peng, et al.
Publicado: (2020)

Lopinavir/ritonavir: Hepatobiliary disorder and hypertriglyceridaemia following off label use: case report
Publicado: (2021)

Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol
por: Nichols, Gregory A., et al.
Publicado: (2018)

Diabetic ketoacidosis with acute severe hypertriglyceridaemia-induced pancreatitis as first presentation of type 2 diabetes
por: Kong, Man Tek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mgl6tig2pm3nhe2tpme0ir5jb4